In Japan, bariatric surgery for T1DM has been reported only for cases of SPIDDM [10, 11]; in these cases, it was possible to reduce or discontinue insulin preparations and oral glycemic drugs after surgery. The gene discussed is INS; the disease is type 1 diabetes mellitus.